Patents-Review.com
ClassID:

20462 ⎘

A61K31/5575 - page 3 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E, prostaglandin F

Recent Application in this class:
#601
20140308350
2014-10-16

NSAID ADMINISTRATION AND RELATED COMPOSITIONS, METHODS AND SYSTEMS

 #602
20140303166
2014-10-09

COSMETIC METHOD FOR CHANGING THE APPEARANCE OF EYES

 #603
20140294750
2014-10-02

AQUEOUS PHARMACEUTICAL COMPOSITIONS CONTAINING BORATE-POLYOL COMPLEXES

 #604
20140287988
2014-09-25

MACROGOL 15 HYDROXYSTEARATE FORMULATIONS

 #605
20140284354
2014-09-25

Reconstitution device

 #606
20140275161
2014-09-18

Combination therapy

 #607
20140275131
2014-09-18

Organic compounds

 #608
20140271876
2014-09-18

Ophthalmic formulations

 #609
20140256726
2014-09-11

Preservative free bimatoprost and timolol solutions

 #610
20140249153
2014-09-04

FIXED DOSE COMBINATION OF BIMATOPROST AND BRIMONIDINE

 #611
20140243409
2014-08-28

Pharmaceutical compositions having desirable bioavailability

 #612
20140235681
2014-08-21

Combination therapy for glaucoma

 #613
20140235665
2014-08-21

ANTI-CONSTIPATION COMPOSITION

 #614
20140234271
2014-08-21

COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS

 #615
20140221493
2014-08-07

Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists

 #616
20140220063
2014-08-07

Vaccine composition

 #617
20140213654
2014-07-31

PROSTAGLANDIN COMPOSITIONS AND METHODS FOR THE TREATMENT OF VASOSPASM

 #618
20140213646
2014-07-31

Sustained release formulations for the treatment of intraocular pressure of glaucoma

 #619
20140206766
2014-07-24

PROSTAGLANDIN COMPOSITIONS AND METHODS FOR THE TREATMENT OF VASOSPASM

 #620
20140205649
2014-07-24

Solvent cast film sustained release latanoprost implant

 #621
20140200274
2014-07-17

Methods and compositions for treating Raynaud's disease

 #622
20140194520
2014-07-10

Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

 #623
20140194501
2014-07-10

Composition for eyelash growth

 #624
20140194450
2014-07-10

TOPICAL TREATMENT FOR CHEMOTHERAPY INDUCED EYELASH LOSS OR HYPOTRICHOSIS USING PROSTAMIDE F2 ALPHA AGONISTS

 #625
20140187642
2014-07-03

Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists

 #626
20140187599
2014-07-03

Methods for treating diseases using isoindoline compounds

 #627
20140186420
2014-07-03

DRUG CORES FOR SUSTAINED RELEASE OF THERAPEUTIC AGENTS

 #628
20140171490
2014-06-19

Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients

 #629
20140171445
2014-06-19

TREATMENT AND PREVENTION OF DISEASES MEDIATED BY MICROORGANISMS VIA DRUG-MEDIATED MANIPULATION OF THE EICOSANOID BALANCE

 #630
20140163098
2014-06-12

Compositions and methods for reducing body fat

 #631
20140162992
2014-06-12

Topical dihydrotestosterone (DHT) for promoting hair growth—containing formulations

 #632
20140161863
2014-06-12

Drug delivery methods, structures, and compositions for nasolacrimal system

 #633
20140155488
2014-06-05

Compositions and methods for stimulating hair growth

 #634
20140148455
2014-05-29

Preservative free bimatoprost and timolol solutions

 #635
20140142188
2014-05-22

PROSTAGLANDIN COMPOSITIONS AND METHODS FOR THE TREATMENT OF VASOSPASM

 #636
20140128329
2014-05-08

Ophthalmic compositions comprising polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymers

 #637
20140121209
2014-05-01

Compositions and methods for lowering intraocular pressure

 #638
20140107124
2014-04-17

Prostamides for the treatment of glaucoma and related diseases

 #639
20140100287
2014-04-10

Enhanced bimatoprost ophthalmic solution

 #640
20140088107
2014-03-27

OPHTHALMIC PREPARATION COMPRISING A PGF2ALPHA ANALOGUE

 #641
20140086973
2014-03-27

PHARMACEUTICAL PREPARATION

 #642
20140079655
2014-03-20

Compositions for enhancing nail health

 #643
20140051704
2014-02-20

Hypotensive lipid and timolol compositions and methods of using same

 #644
20140045945
2014-02-13

Intracameral sustained release therapeutic agent implants

 #645
20140045933
2014-02-13

Methods and compositions for treating metabolic syndrome

 #646
20140039058
2014-02-06

Ophthalmic solution

 #647
20140031767
2014-01-30

Dual cap system for container-closures to maintain tip sterility during shelf storage

 #648
20140025022
2014-01-23

Drug delivery system and methods of treating open angle glaucoma and ocular hypertension

 #649
20140024587
2014-01-23

Compositions and methods for treating hair loss using non-naturally occurring prostaglandins

 #650
20140018430
2014-01-16

Composition for the treatment of cystic fibrosis

 #651
20140018396
2014-01-16

Composition for treating or preventing glaucoma comprising a sulfonamide compound, and a beta-receptor antagonist

 #652
20130331389
2013-12-12

Methods and Compositions for Cardiomyocyte Replenishment by Endogenous and Progenitor Stem Cells

 #653
20130331363
2013-12-12

PDE1 inhibitory compounds and methods

 #654
20130324565
2013-12-05

PDE1 inhibitor compounds

 #655
20130324481
2013-12-05

Sustained release eye drop formulations

 #656
20130310370
2013-11-21

DRUG THERAPY FOR PREVENTING OR TREATING GLAUCOMA

 #657
20130309330
2013-11-21

Compositions comprising a prostaglandin for treating neuropsychiatric conditions

 #658
20130303566
2013-11-14

METHOD FOR TREATING MACULAR DEGENERATION

 #659
20130281454
2013-10-24

Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use

 #660
20130280233
2013-10-24

CBP/Catenin antagonists for enhancing asymmetric division of somatic stem cells

 #661
20130273164
2013-10-17

Nanotechnology approach for inhalation therapies

 #662
20130253049
2013-09-26

Treatment for pulmonary hypertension

 #663
20130245124
2013-09-19

PRESERVATIVE FREE BIMATOPROST SOLUTIONS

 #664
20130216606
2013-08-22

Liposomal formulation for ocular drug delivery

 #665
20130203854
2013-08-08

Enhanced bimatoprost ophthalmic solution

 #666
20130203784
2013-08-08

Valaciclovir and diclofenac combination therapy for functional somatic syndromes

 #667
20130203780
2013-08-08

Method of treating functional somatic syndromes with combination of famciclovir and diclofenac

 #668
20130203743
2013-08-08

Famciclovir and meloxicam combination therapy for functional somatic syndromes

 #669
20130202704
2013-08-08

USE OF MEXIPROSTIL IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE AND/OR OF IRRITABLE BOWEL SYNDROME

 #670
20130197093
2013-08-01

Enhanced bimatoprost ophthalmic solution

 #671
20130197081
2013-08-01

INTRAVAGINAL ADMINISTRATION OF MISOPROSTOL

 #672
20130195936
2013-08-01

OPHTHALMIC OIL-IN-WATER EMULSIONS CONTAINING PROSTAGLANDINS

 #673
20130184295
2013-07-18

Method of identifying therapies for pulmonary hypertension

 #674
20130136700
2013-05-30

Poly-hapten with topical hormone alopecia hair regrowth system

 #675
20130130971
2013-05-23

Method for inhibiting HIV replication in mammal and human cells

 #676
20130129807
2013-05-23

Collagen-based implants for sustained delivery of drugs

 #677
20130116254
2013-05-09

COMPOSITIONS AND METHODS FOR LOWERING INTRAOCULAR PRESSURE

 #678
20130116177
2013-05-09

Methods of administering an aromatase inhibitor, prostaglandin and GnRH for regulating ovulation in cattle

 #679
20130096200
2013-04-18

TREPROSTINIL TREATMENT FOR INTERSTITIAL LUNG DISEASE AND ASTHMA

 #680
20130089508
2013-04-11

COMPOSITIONS FOR ENHANCING NAIL HEALTH

 #681
20130079414
2013-03-28

Enhanced bimatoprost ophthalmic solution

 #682
20130079290
2013-03-28

S1P ANTAGONISTS AS ADJUNCT OCULAR HYPOTENSIVES

 #683
20130078303
2013-03-28

Soft-gelatin capsule formulation

 #684
20130053794
2013-02-28

SUSTAINED RELEASE DELIVERY OF ACTIVE AGENTS TO TREAT GLAUCOMA AND OCULAR HYPERTENSION

 #685
20130046014
2013-02-21

Pharmaceutical composition for treatment of increased intraocular pressure

 #686
20130041025
2013-02-14

COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS, HAIR THINNING, AND HAIR COLOR LOSS

 #687
20130035393
2013-02-07

Method for treating schizophrenia

 #688
20130035338
2013-02-07

EYELID TREATMENT

 #689
20130030055
2013-01-31

COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS, HAIR THINNING, AND HAIR COLOR LOSS

 #690
20130028883
2013-01-31

Treatment of ischemic episodes and cerebroprotection through misoprostol

 #691
20130023536
2013-01-24

FIXED DOSE COMBINATION OF BIMATOPROST AND BRIMONIDINE

 #692
20130018360
2013-01-17

METHOD FOR DELIVERING OPHTHALMIC DRUGS

 #693
20130017268
2013-01-17

Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof

 #694
20130017243
2013-01-17

SUSTAINED-RELEASE RESERVOIR IMPLANTS FOR INTRACAMERAL DRUG DELIVERY

 #695
20130005805
2013-01-03

Esters for treatment of ocular inflammatory conditions

 #696
20130005737
2013-01-03

Compositions, methods and kits for treating leukemia

 #697
20130005691
2013-01-03

Esters for treatment of ocular inflammatory conditions

 #698
20130005665
2013-01-03

MACROGOL 15 HYDROXYSTEARATE FORMULATIONS

 #699
20120322882
2012-12-20

Compositions And Methods For Stimulating Hair Growth

 #700
20120322871
2012-12-20

Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives

 #701
20120322746
2012-12-20

METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF OPHTHALMIC DISORDERS

 #702
20120316243
2012-12-13

Enhanced bimatoprost ophthalmic solution

 #703
20120316241
2012-12-13

REMEDY FOR CARTILAGE-RELATED DISEASES

 #704
20120289603
2012-11-15

Enhanced bimatoprost ophthalmic solution

 #705
20120277694
2012-11-01

PUNCTAL PLUG WITH ACTIVE AGENT

 #706
20120277299
2012-11-01

METHOD FOR MODULATING ION TRANSPORTER

 #707
20120276186
2012-11-01

SUSTAINED RELEASE LATANOPROST IMPLANT

 #708
20120276184
2012-11-01

Solvent cast film sustained release latanoprost implant

 #709
20120270945
2012-10-25

METHOD FOR MODULATING CYTOKINE ACTIVITY

 #710
20120270941
2012-10-25

Topical application of travoprost for combating hair loss

 #711
20120263803
2012-10-18

AQUEOUS OPHTHALMIC COMPOSITION

 #712
20120259008
2012-10-11

Method for treating asthenopia

 #713
20120258988
2012-10-11

Therapeutic or prophylactic agent for diabetes

 #714
20120245227
2012-09-27

Pharmaceutical compositions having desirable bioavailability

 #715
20120245088
2012-09-27

COMPOSITIONS COMPRISING IGF1 AGONISTS AND USES THEREOF

 #716
20120238994
2012-09-20

TWO-PIECE INJECTABLE DRUG DELIVERY DEVICE WITH HEAT-CURED SEAL

 #717
20120238993
2012-09-20

TWO-PIECE INJECTABLE DRUG DELIVERY DEVICE WITH HEAT-CURED SEAL

 #718
20120238633
2012-09-20

Hypotensive prostamide-containing biodegradable intraocular implants and related methods

 #719
20120237598
2012-09-20

Anti-constipation composition

 #720
20120232139
2012-09-13

COMPOSITION FOR OCULAR TOPICAL ADMINISTRATION TREATMENT OCULAR HYPERTENSION AND GLAUCOMA

 #721
20120225939
2012-09-06

Use of prostaglandins F2Alpha and analogues for the healing of corneal and conjunctival lesions

 #722
20120219611
2012-08-30

Hypotensive lipid-containing biodegradable intraocular implants and related methods

 #723
20120209011
2012-08-16

NOVEL PROCESS FOR THE PREPARATION OF PROSTAGLANDINS AND INTERMEDIATES THEREOF

 #724
20120202773
2012-08-09

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DISEASES ASSOCIATED WITH DECREASE IN BONE MASS COMPRISING EP4 AGONIST AS ACTIVE INGREDIENT

 #725
20120190739
2012-07-26

EP2 and EP4 agonists as agents for the treatment of influenza a viral infection

 #726
20120190733
2012-07-26

Compounds and methods for enhancing hair growth

 #727
20120187594
2012-07-26

Drug cores for sustained release of therapeutic agents

 #728
20120184622
2012-07-19

COMPOSITION FOR THE TREATMENT OF CYSTIC FIBROSIS

 #729
20120184615
2012-07-19

Stabilised prostaglandin composition

 #730
20120184552
2012-07-19

LATANOPROST-CONTAINING AQUEOUS EYE DROPS AND METHOD FOR INHIBITING ADSORPTION OF LATANOPROST TO RESIN

 #731
20120165293
2012-06-28

Synthesis of prostanoids

 #732
20120164186
2012-06-28

Diketopiperazine microparticles with defined specific surface areas

 #733
20120156699
2012-06-21

Pathogenic TH17 Cells; related reagents and methods

 #734
20120142783
2012-06-07

Enhanced bimatoprost ophthalmic solution

 #735
20120142782
2012-06-07

Enhanced bimatoprost ophthalmic solution

 #736
20120141590
2012-06-07

Technology for the Preparation of Microparticles

 #737
20120136322
2012-05-31

Anterior segment drug delivery

 #738
20120129941
2012-05-24

TREPROSTINIL TREATMENT FOR INTERSTITIAL LUNG DISEASE AND ASTHMA

 #739
20120129789
2012-05-24

COMPOSITIONS AND METHODS FOR HAIR GROWTH

 #740
20120122976
2012-05-17

PHOSPHATE-FREE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GLAUCOMA

 #741
20120122787
2012-05-17

METHODS FOR TREATING POLYCYSTIC KIDNEY DISEASE (PKD) OR OTHER CYST FORMING DISEASES

 #742
20120087864
2012-04-12

METHOD FOR DIAGNOSING AND/OR EVALUATING RETINAL DISEASE

 #743
20120077756
2012-03-29

Methods, compositions, and kits for the treatment of ophthalmic disorders

 #744
20120071510
2012-03-22

Method and composition for treating migraines

 #745
20120071450
2012-03-22

Organic compounds

 #746
20120070369
2012-03-22

HIF inhibitors and use thereof

 #747
20120058167
2012-03-08

Methods for treating scars and aging skin

 #748
20120058076
2012-03-08

Aesthetic treatment of scars and aging skin

 #749
20120046242
2012-02-23

MOLECULAR ACTIVATORS OF THE WNT/BETA-CATENIN PATHWAY

 #750
20120040994
2012-02-16

THERAPEUTIC AGENT FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDIN

 #751
20120029073
2012-02-02

Pharmaceutical compositions having desirable bioavailability

 #752
20120022164
2012-01-26

EXTERNAL PREPARATION COMPRISING PROSTAGLANDIN DERIVATIVE

 #753
20120022152
2012-01-26

Anti-constipation composition

 #754
20120015001
2012-01-19

Methods of treating thyroid eye disease

 #755
20120014999
2012-01-19

Diketopiperazine microparticles with defined specific surface areas

 #756
20120010288
2012-01-12

Method for protecting a retinal neuronal cell

 #757
20110319488
2011-12-29

Anionic oil-in-water emulsions containing prostaglandins and uses thereof

 #758
20110319487
2011-12-29

POLYMERIC DELIVERY SYSTEM FOR A NONVISCOUS PROSTAGLANDIN-BASED SOLUTION WITHOUT PRESERVATIVES

 #759
20110313038
2011-12-22

CATIONIC OIL-IN-WATER EMULSIONS CONTAINING PROSTAGLANDINS AND USES THEREOF

 #760
20110312978
2011-12-22

PDE1 inhibitors for ophthalmic disorders

 #761
20110301105
2011-12-08

Compositions for proliferation of cells and related methods

 #762
20110300211
2011-12-08

Soft-gelatin capsule formulation

 #763
20110295034
2011-12-01

Eye drop composition containing isopropyl unoprostone

 #764
20110294893
2011-12-01

NON-ACIDIC CYCLOPENTANE HEPTANOIC ACID, 2-CYCLOALKYL OR ARYLALKYL DERIVATIVES AS THERAPEUTIC AGENTS

 #765
20110294880
2011-12-01

Pharmaceutical composition containing prostaglandin

 #766
20110276131
2011-11-10

Nasolacrimal drainage system implants for drug therapy

 #767
20110275715
2011-11-10

METHOD FOR TREATING RETINAL DISEASE

 #768
20110275711
2011-11-10

METHOD FOR TREATING MACULAR EDEMA

 #769
20110265786
2011-11-03

Inhalable Formulations For Treating Pulmonary Hypertension And Methods Of Using Same

 #770
20110263498
2011-10-27

Method and composition for enhancement of male erectile function

 #771
20110250285
2011-10-13

Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and prostamide

 #772
20110245214
2011-10-06

Organic compounds

 #773
20110224236
2011-09-15

Treatment for pulmonary hypertension

 #774
20110182966
2011-07-28

Intracameral sustained release therapeutic agent implants

 #775
20110172435
2011-07-14

Geminal dialkyl prostanoids

 #776
20110172177
2011-07-14

Combination, kit and method of reducing intraocular pressure

 #777
20110152373
2011-06-23

Hair growth promoting agent containing 15,15-difluoroprostaglandin F derivative as active ingredient

 #778
20110152328
2011-06-23

Combination Therapy For Glaucoma

 #779
20110152264
2011-06-23

Method and composition for treating ocular hypertension and glaucoma

 #780
20110144204
2011-06-16

Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

 #781
20110136818
2011-06-09

Therapeutic compositions containing macitentan

 #782
20110124737
2011-05-26

Enhanced bimatoprost ophthalmic solution

 #783
20110124736
2011-05-26

COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH

 #784
20110118349
2011-05-19

Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions

 #785
20110118348
2011-05-19

Methods of stabilizing latanoprost in an aqueous solution

 #786
20110105605
2011-05-05

METHOD OF PREPARING A LATANOPROST OPHTHALMIC SOLUTION AND THE RESULTING SOLUTION

 #787
20110105558
2011-05-05

Eye-drop preparation and use thereof

 #788
20110104144
2011-05-05

METHODS FOR TREATING CUTANEOUS LUPUS USING AMINOISOINDOLINE COMPOUNDS

 #789
20110098355
2011-04-28

METHOD OF PREPARING A LATANOPROST OPHTHALMIC SOLUTION AND RESULTING SOLUTION

 #790
20110098354
2011-04-28

METHOD OF PREPARING A LATANOPROST OPHTHALMIC SOLUTION AND THE RESULTING SOLUTION

 #791
20110065790
2011-03-17

Latanoprost-containing aqueous pharmaceutical composition

 #792
20110064748
2011-03-17

Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor

 #793
20110062165
2011-03-17

Therapeutic substituted cyclopentanes

 #794
20110054016
2011-03-03

Method for modulating claudin mediated functions

 #795
20110038884
2011-02-17

IMMUNOPOTENTIATING AGENT COMPRISING EP1 AGONIST

 #796
20110034424
2011-02-10

METHOD FOR THE LONG TERM NSAID USE

 #797
20110028477
2011-02-03

Stable ophthalmic formulations

 #798
20110027223
2011-02-03

Use of electrophilic compounds for inducing platelet production or maintaining platelet function

 #799
20110015238
2011-01-20

Blood flow promoters for cauda equina tissues

 #800
20110009370
2011-01-13

Method to enhance tissue regeneration

 #801
20100331407
2010-12-30

Clear ophthalmic solution comprising latanoprost as active ingredient

 #802
20100305203
2010-12-02

METHOD FOR MODULATING CLAUDIN MEDIATED FUNCTIONS

 #803
20100298424
2010-11-25

METHOD FOR TREATING ABDOMINAL DISCOMFORT

 #804
20100280250
2010-11-04

THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS

 #805
20100278898
2010-11-04

Intraocular pressure reduction with intracameral bimatoprost implants

 #806
20100278875
2010-11-04

PROSTAGLANDIN E2 (PGE2) AS AN ADJUVANT IN MONOCLONAL ANTIBODY GENERATION

 #807
20100267832
2010-10-21

Method for treating macular degeneration

 #808
20100267826
2010-10-21

Treatment of ischemic episodes and cerebroprotection through Prostaglandin E2 (PGE2) EP2 and/or EP4 receptor agonists

 #809
20100247606
2010-09-30

INTRAOCULAR SUSTAINED RELEASE DRUG DELIVERY SYSTEMS AND METHODS FOR TREATING OCULAR CONDITIONS

 #810
20100234466
2010-09-16

Compositions and methods for reducing body fat

 #811
20100216877
2010-08-26

Storage Stable Prostaglandin Product

 #812
20100216710
2010-08-26

Methods for stimulating nervous system regeneration and repair by regulating arginase I and polyamine synthesis

 #813
20100216689
2010-08-26

Cytotoxic T cell activator comprising EP4 agonist

 #814
20100210720
2010-08-19

Preservative-free prostaglandin-based ophthalmic solution

 #815
20100209477
2010-08-19

SUSTAINED RELEASE DELIVERY OF ONE OR MORE AGENTS

 #816
20100204332
2010-08-12

METHOD FOR TREATING A DISEASE OR CONDITION RESPONSIVE TO OPENING OF C1C-2 CHANNEL

 #817
20100204331
2010-08-12

Prostaglandin derivative-containing aqueous liquid preparation

 #818
20100204320
2010-08-12

PHARMACEUTICALS FOR XEROSIS

 #819
20100196471
2010-08-05

Tablet dosage form

 #820
20100190853
2010-07-29

Topical application of travoprost for combating hair loss

 #821
20100143289
2010-06-10

UMBILICAL CORD STEM CELL SECRETED PRODUCT DERIVED TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF

 #822
20100137432
2010-06-03

Ophthalmic composition comprising a prostaglandin

 #823
20100136111
2010-06-03

PHARMACEUTICAL COMPOSITIONS OF DICLOFENAC AND MISOPROSTOL

 #824
20100135998
2010-06-03

COMBINATION THERAPY FOR TREATMENT OF IMMUNE DISORDERS

 #825
20100120908
2010-05-13

EYE DROP PREPARATION COMPRISING LATANOPROST

 #826
20100113370
2010-05-06

METHODS AND COMPOUNDS FOR MODULATING INFLAMMATORY PROCESSES

 #827
20100112066
2010-05-06

Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent

 #828
20100112027
2010-05-06

Penis Enlargement

 #829
20100112016
2010-05-06

Ophthalmic oil-in-water emulsions containing prostaglandins

 #830
20100105775
2010-04-29

Amino acid salts of prostaglandins

 #831
20100105771
2010-04-29

Amino acid salts of prostaglandins

 #832
20100104654
2010-04-29

PROSTAGLANDIN AND PROSTAMIDE DRUG DELIVERY SYSTEMS AND INTRAOCULAR THERAPEUTIC USES THEREOF

 #833
20100063060
2010-03-11

Therapeutic agent for glaucoma comprising Rho Kinhase inhibitor and prostaglandin

 #834
20100041758
2010-02-18

Adhesive preparation

 #835
20100041671
2010-02-18

Methods for treating glaucoma

 #836
20100040670
2010-02-18

DRUG DELIVERY VIA OCULAR IMPLANT

 #837
20100016427
2010-01-21

EXTERNAL PREPARATION COMPRISING PROSTAGLANDIN DERIVATIVE

 #838
20100010222
2010-01-14

Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient

 #839
20090318549
2009-12-24

COMBINATION TREATMENT OF GLAUCOMA

 #840
20090317479
2009-12-24

Nanoparticles containing water-soluble non-peptide low-molecular weight drug

 #841
20090297497
2009-12-03

Methods and compositions for treating nephrogenic diabetes and insipidus

 #842
20090286769
2009-11-19

Compositions and methods for treating hair loss using non-naturally occurring prostaglandins

 #843
20090280158
2009-11-12

Sustained release delivery of active agents to treat glaucoma and ocular hypertension

 #844
20090264523
2009-10-22

Method for prevention of degradation of thermally unstable medicament

 #845
20090252716
2009-10-08

METHODS FOR IDENTIFYING NUCLEAR RECEPTOR/LIGAND COMBINATIONS FOR TARGETING BRAIN TUMOR STEM CELLS AND FOR THEIR USE

 #846
20090234013
2009-09-17

Pharmaceutical compositions having desirable bioavailability

 #847
20090234005
2009-09-17

Protective agent for retinal neuronal cell containing prostaglandin f2alpha derivative as active ingredient

 #848
20090234004
2009-09-17

PHARMACEUTICAL COMPOSITIONS HAVING DESIRABLE BIOAVAILABILITY

 #849
20090232763
2009-09-17

AQUEOUS PHARMACEUTICAL COMPOSITIONS CONTAINING BORATE-POLYOL COMPLEXES

 #850
20090227672
2009-09-10

Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents

 #851
20090209643
2009-08-20

Method for modulating stem cell growth

 #852
20090197892
2009-08-06

ANHYDROUS COMPOSITIONS USEFUL FOR ATTAINING ENHANCED SEXUAL WELLNESS

 #853
20090181969
2009-07-16

Hypotensive lipid and timolol compositions and methods of using same

 #854
20090170931
2009-07-02

EP2 and EP4 agonists as agents for the treatment of influenza a viral infection

 #855
20090155338
2009-06-18

Chronotherapeutic Ocular Delivery System Comprising a Combination of Prostaglandin and a Beta-Blocker for Treating Primary Glaucoma

 #856
20090149546
2009-06-11

Enhanced bimatoprost ophthalmic solution

 #857
20090111891
2009-04-30

Prostaglandin analog compositions to treat epithelial-related conditions

 #858
20090111890
2009-04-30

Prostaglandin analog compositions and methods to treat epithelial-related conditions

 #859
20090111889
2009-04-30

Prostaglandin analog compositions to treat epithelial-related conditions

 #860
20090111888
2009-04-30

Prostaglandin analog compositions and methods to treat epithelial-related conditions

 #861
20090111887
2009-04-30

Prostaglandin analog compositions to treat epithelial-related conditions

 #862
20090111886
2009-04-30

Prostaglandin analog compositions and methods to treat epithelial-related conditions

 #863
20090111885
2009-04-30

Prostaglandin analog compositions to treat epithelial-related conditions

 #864
20090111884
2009-04-30

Prostaglandin analog compositions and methods to treat epithelial-related conditions

 #865
20090111883
2009-04-30

Prostaglandin analog compositions to treat epithelial-related conditions

 #866
20090111882
2009-04-30

Prostaglandin analog compositions and methods to treat epithelial-related conditions

 #867
20090111881
2009-04-30

Prostaglandin analog compositions to treat epithelial-related conditions

 #868
20090111880
2009-04-30

Prostaglandin analog compositions and methods to treat epithelial-related conditions

 #869
20090111761
2009-04-30

Prostaglandin Analog Compositions And Methods To Treat Epithelial-Related Conditions

 #870
20090104243
2009-04-23

Drug cores for sustained release of therapeutic agents

 #871
20090098207
2009-04-16

Technology for the Preparation of Microparticles

 #872
20090092654
2009-04-09

Drug Delivery Methods, Structures, and Compositions for Nasolacrimal System

 #873
20090088473
2009-04-02

METHOD FOR SCREENING OF PROSTAGLANDIN COMPOUNDS COMPRISING AN OPTIMAL FORMULATION FOR THE ENHANCEMENT OF HAIR GROWTH AND THE STIMULATION OF FOLLICULAR ANAGEN AND FORMULATIONS RESULTING THEREFROM

 #874
20090088366
2009-04-02

Nitrosated and nitrosylated prostaglandins, compositions and methods of use

 #875
20090081319
2009-03-26

Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

 #876
20090074844
2009-03-19

TRENADERMAL ABSORPTION PREPARATION

 #877
20090062382
2009-03-05

EXTERNAL PREPARATION FOR IMPROVING COITAL FUNCTION

 #878
20090062381
2009-03-05

AQUEOUS COMPOSITION

 #879
20090054524
2009-02-26

Methods for identifying and using IKK inhibitors

 #880
20090036465
2009-02-05

COMBINATION THERAPY FOR PULMONARY ARTERIAL HYPERTENSION

 #881
20090035289
2009-02-05

DRY PLATELET COMPOSITION

 #882
20090030072
2009-01-29

PHARMACEUTICAL COMBINATION OF OPIOID AND PROSTAGLANDIN COMPOUND

 #883
20090028955
2009-01-29

Ophthalmic emulsions containing an immunosuppressive agent

 #884
20090022787
2009-01-22

Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound

 #885
20080286251
2008-11-20

Compositions and Methods for the Enhancement of Chemotherapy with Microbial Cytotoxins

 #886
20080280986
2008-11-13

TREPROSTINIL TREATMENT FOR INTERSTITIAL LUNG DISEASE AND ASTHMA

 #887
20080268020
2008-10-30

Ophthalmic Emulsions Containing Prostaglandins

 #888
20080241078
2008-10-02

Compositions and methods for treating hair loss using C-Caromatic tetrahydro prostaglandins

 #889
20080234376
2008-09-25

EMULSION COMPOSITION COMPRISING PROSTAGLANDIN E1

 #890
20080234337
2008-09-25

Preventive and/or Remedy for Hyperkalemia Containing Ep4 Agonist

 #891
20080233053
2008-09-25

Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients

 #892
20080207759
2008-08-28

METHOD FOR PROTECTING MITOCHONDRIA

 #893
20080207561
2008-08-28

Biomaterials and a method for making and using same

 #894
20080200948
2008-08-21

Biomaterials and a method for making and using the same

 #895
20080175831
2008-07-24

NEUROPROTECTION BY BLOOD FLOW STABILIZATION

 #896
20080167379
2008-07-10

Ointment

 #897
20080145403
2008-06-19

Low temperature processes for making cyclic lipid implants for intraocular use

 #898
20080139652
2008-06-12

Pharmaceutical Composition Containing Prostaglandin

 #899
20080139648
2008-06-12

Product Containing Prostaglandin Having Fluorine Atom In Its Molecule

 #900
20080131482
2008-06-05

Hypotensive lipid-containing biodegradable intraocular implants and related methods